Form 4 for BNGO Bionano Genomics, Inc.
Accepted 2025-09-12 00:00:00 ET · period of report 2025-09-11 · accession 0001745566-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-12 | 2025-09-11 | BNGO | OLDAKOWSKI MARK | COO | F - Tax | $4.06 | -59 | 915 | -6% | -$239.54 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-11 | F | D | 59 | $4.06 | 915 | D | — | — | (F1) The reporting person is reporting the withholding by the Issuer an aggregate of 59 shares of common stock that vested on September 11, 2025, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. |